Search Results

You are looking at 31 - 35 of 35 items for :

  • Emergency Medicine and Intensive-Care Medicine x
Clear All
Open access

Irina Magdalena Dumitru, Eugen Dumitru, Sorin Rugina and Liliana Ana Tuta

difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality. Clin Infect Dis. 2015;61(2):233-41. 22. Dubberke ER, Sadhu J, Gatti R, et al. Severity of Clostridium difficile-associated disease (CDAD) in allogeneic stem cell transplant recipients: evaluation of a CDAD severity grading system. Infect Control Hosp Epidemiol. 2007;28:208–11. 23. Henrich TJ, Krakower D, Bitton A, Yokoe DS. Clinical Risk Factors for Severe Clostridium difficile–associated Disease. Emerg Infect Dis. 2009

Open access

Balázs Oltean-Péter, István Kovács, Monica Chițu and Imre Benedek

;163:517-522. 34. Mester A, Oltean-Péter B, Rodean I, et al. Magnetic Resonance Imaging of Myocardial Function Following Intracoronary and Intramyocardial Stem Cell Injection. Journal of Interdisciplinary Medicine . 2017;2:112-116. 35. Inzitari D, Eliasziw M, Gates P, et al. The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med . 2000;342:1693-1700. 36. Fox Allan J. How to measure carotid stenosis. Radiology . 1993;186:316-318. 37

Open access

Ioana Rodean, Elena Beganu, Roxana Hodas, Elisabeta Himcinschi, Lehel Bordi and Theodora Benedek

Imaging of Myocardial Function Following Intracoronary and Intramyocardial Stem Cell Injection. Journal of Interdisciplinary Medicine . 2017;2:112-116. 8. Bax JJ, Delgado V. Myocardial viability as integral part of the diagnostic and therapeutic approach to ischemic heart failure. J Nucl Cardiol . 2015;22:229-245. 9. Saeed M, Liu H, Liang CH, Wilson MW. Magnetic resonance imaging for characterizing myocardial diseases. Int J Cardiovasc Imaging . 2017. doi: 10.1007/s10554-017-1127-x. [Epub ahead of print] 10. Buckert D, Kelle S, Buss S, et al. Left

Open access

Ioana-Aurița Albu-Stan, Daniel-Emil Albu, Diana Cerghizan, Lia Yero Eremie, Kinga Jánosi, Monica Baloș and Constantin Copotoiu

;101:11-23. 58. Agrillo A, Filiaci F, Ramieri V, Riccardi E, Quarato D, Rinna C. Bisphosphonate-related osteonecrosis of the jaw (BRONJ): 5 year experience in the treatment of 131 cases with ozone therapy. Eur Rev Med Pharmacol Sci . 2012;16:1741–1747. 59. Gonzálvez-García M, Rodríguez-Lozano FJ, Villanueva V, Segarra-Fenoll D, Rodríguez-González MA, Oñate-Sánchez R. Cell therapy in bisphosphonate-related osteonecrosis of the jaw. J Craniofac Surg . 2013;24:e226–e228. 60. Cella L, Oppici A, Arbasi M, Moretto M, Piepoli M, Vallisa D. Autologous bone marrow stem

Open access

Theodora Benedek, Monica Marton Popovici and Dietmar Glogar

.0012. 3. Gyongyosi M, Hemetsberger R, Posa A, et al. Hypoxia-inducible Factor 1-Alp[ha Release After Intracoronary versus Intramyocardial Stem Cell Therapy in Myocardial Infarction. J Cardiovasc Translational Res. 2010;3:114-21. doi: 10.1007/s12265-009-9154-1. 4. Benedek I, Gyongyosi M, Benedek T. A prospective regional registry of ST-elevation myocardial infarction in central Romania. Impact of the Stent for Life initiative recommendations on patient outcomes. Am Heart J. 2013;166:457-65. doi: 10.1016/j.ahj.2013.03.033. 5. Avalli L, Maggioni E, Formica F